2m 2m 2m 2m 2m 2m 2m
INDIVIOR PHARMA (INDV)
NASDAQ
$35.76+$0.43 (+1.20%)
Price as of Oct 22, 2026 7:39 PM EDT- $4.1BMarket Cap
- 39.75%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
INDIVIOR PHARMA (INDV)
$35.76+$0.43 (+1.20%)
INDV | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $35.33 | ||
Change | +$0.54 (+1.55%) | ||
Open | $34.77 | ||
High | $35.36 | ||
Low | $34.54 | ||
Previous Close | $34.79 | ||
Volume | 871,702 | ||
30-Day Average Volume | 2,397,295 | ||
1-Week Change | 5.09% | ||
1-Month Change | -2.38% | ||
1-Year Change | 39.75% | ||
3-Year Change | 89.95% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 118.0M | ||
Total Assets | $1.2B | ||
Market Cap | $4.1B | ||
Enterprise Value | $4.4B | ||
Period: QTR TTM FY | |||
Revenue | $343.0M | ||
Net Income | $122.0M | ||
Free Cash Flow | $222.0M | ||
EBIT | $160.0M | ||
EBITDA | $162.0M | ||
Net Working Capital | -$143.0M | ||
EPS | $0.98 | ||
Enterprise Value/EBITDA | 27 | ||
Enterprise Value/Revenue | 13 | ||
P/B | -20 | ||
P/E | 36 | ||
PEG | 1 | ||
Price/Free Cash Flow | 18 | ||
Price/Operating Cash Flow | 18 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 11/03/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue